Surgery for primary hyperparathyroidism in Germany, Switzerland, and Austria: an analysis of data from the EUROCRINE registry
- PMID: 37055669
- PMCID: PMC10102096
- DOI: 10.1007/s00423-023-02819-2
Surgery for primary hyperparathyroidism in Germany, Switzerland, and Austria: an analysis of data from the EUROCRINE registry
Abstract
Purpose: EUROCRINE is an endocrine surgical register documenting diagnostic processes, indication for surgical treatment, surgical procedures, and outcomes. The purpose was to analyse data for PHPT in German speaking countries regarding differences in clinical presentation, diagnostic workup, and treatment.
Methods: All operations for PHPT performed from 07/2015 to 12/2019 were analysed.
Results: Three thousand two hundred ninety-one patients in Germany (9 centres; 1762 patients), Switzerland (16 centres; 971 patients) and Austria (5 centres; 558 patients) were analysed. Hereditary disease was seen in 36 patients in Germany, 16 patients in Switzerland and 8 patients in Austria. In sporadic disease before primary operation, PET-CT showed the highest sensitivity in all countries. In re-operations, CT and PET-CT achieved the highest sensitivities. The highest sensitivity of IOPTH was seen in Austria (98.1%), followed by Germany (96.4%) and Switzerland (91.3%). Operation methods and mean operative time reached statistical significance (p<0.05). Complication rates are low. Overall, 656 (19.9%) patients were asymptomatic; the remainder showed bone manifestations, kidney stones, fatigue and/or neuropsychiatric symptoms.
Conclusion: Early postoperative normocalcaemia ranged between 96.8 and 97.1%. Complication rates are low. PET-CT had the highest sensitivity in all three countries in patients undergoing primary operation as well as in Switzerland and Austria in patients undergoing re-operation. PET-CT could be considered a first-line preoperative imaging modality in patients with inconclusive ultrasound examination. The EUROCRINE registry is a beneficial and comprehensive data source for outcome analysis of endocrine procedures on a supranational level.
Keywords: EUROCRINE; Intraoperative monitoring; Parathyroid hormone; Primary hyperparathyroidism; Surgery.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
[EUROCRINE®: adrenal surgery 2015-2019- surprising initial results].Chirurg. 2021 May;92(5):448-463. doi: 10.1007/s00104-020-01277-6. Chirurg. 2021. PMID: 32945919 Free PMC article. German.
-
Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).Langenbecks Arch Surg. 2021 May;406(3):571-585. doi: 10.1007/s00423-021-02173-1. Epub 2021 Apr 21. Langenbecks Arch Surg. 2021. PMID: 33880642 Review.
-
Surgical treatment in patients with single and multiple gland primary hyperparathyroidism with the use of intraoperative parathyroid hormone monitoring: extensive single-center experience.Hormones (Athens). 2019 Sep;18(3):273-279. doi: 10.1007/s42000-019-00121-9. Epub 2019 Jul 22. Hormones (Athens). 2019. PMID: 31332766
-
Effectiveness of Intraoperative Parathyroid Monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease.Int J Surg. 2017 May;41 Suppl 1:S26-S33. doi: 10.1016/j.ijsu.2017.02.063. Int J Surg. 2017. PMID: 28506410
-
Use of Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.JAMA Otolaryngol Head Neck Surg. 2021 Feb 1;147(2):135-143. doi: 10.1001/jamaoto.2020.4021. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33211086 Free PMC article.
Cited by
-
Is intraoperative parathyroid monitoring during minimally invasive parathyroidectomy still justified?Front Endocrinol (Lausanne). 2024 Jul 22;15:1442972. doi: 10.3389/fendo.2024.1442972. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39104811 Free PMC article.
-
Endocrinology application of molecular imaging: current role of PET/CT.J Endocrinol Invest. 2024 Oct;47(10):2383-2396. doi: 10.1007/s40618-024-02400-8. Epub 2024 Jun 5. J Endocrinol Invest. 2024. PMID: 38837101 Free PMC article. Review.
-
Turning Points in Cross-Disciplinary Perspective of Primary Hyperparathyroidism and Pancreas Involvements: Hypercalcemia-Induced Pancreatitis, MEN1 Gene-Related Tumors, and Insulin Resistance.Int J Mol Sci. 2024 Jun 8;25(12):6349. doi: 10.3390/ijms25126349. Int J Mol Sci. 2024. PMID: 38928056 Free PMC article. Review.
-
Perioperative characteristics and short-term morbidity after surgery for renal hyperparathyroidism: multicentre EUROCRINE® registry study.BJS Open. 2025 May 7;9(3):zraf048. doi: 10.1093/bjsopen/zraf048. BJS Open. 2025. PMID: 40503605 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources